Senti Biosciences
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Senti Biosciences sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).
Senti Biosciences: 1 sponsored US clinical trial, none currently recruiting.
Senti Biosciences sponsors 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is FLT3 Expressing Hematological Malignancies, with 1 trials.
Mid-pack sponsor footprint
Senti Biosciences is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
Indexed trials (enrollment closed)
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
How the Senti Biosciences early-phase archive is shaped
1 indexed studies, none listed as recruiting (0% open).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: FLT3 Expressing Hematological Malignancies (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Senti Biosciences: archived-pipeline peers nationwide
Peers matched on 1 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Senti Biosciences sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1 archived trials
- 1200 Pharma · 2 trials · 50% recruiting
- 1ST Biotherapeutics · 2 trials · 50% recruiting
- 3 Waves Wellness · 2 trials · 0% recruiting
- 3EO Health · 2 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Senti Biosciences page
1 registered trials is a research-attention snapshot, not an endorsement of Senti Biosciences or any single study.
- None of Senti Biosciences's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- FLT3 Expressing Hematological Malignancies is the condition Senti Biosciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See FLT3 Expressing Hematological Malignancies trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Senti Biosciences pipeline card: 1 registered trials from official public datasets.Report a data error.